We are live on
!
Find out more
VRM
Vectors Research Management Portfolio holdings
AUM
$383M
1-Year Est. Return
30.23%
This Fund
S&P 500
This Quarter
Est. Return
+6.1%
1 Year Est. Return
+30.23%
3 Year Est. Return
+67.25%
5 Year Est. Return
+74.92%
10 Year Est. Return
–
AUM
$355M
AUM Growth
+$46.4M
(+15%)
Cap. Flow
+$238M
Cap. Flow
% of AUM
66.98%
Top 10 Holdings %
Top 10 Hldgs %
43.09%
Holding
142
New
18
Increased
36
Reduced
68
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$79.1M |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$54.7M |
| 3 |
Microsoft
MSFT
|
+$48.8M |
| 4 |
Procter & Gamble
PG
|
+$33.4M |
| 5 |
IBM
IBM
|
+$18.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Variable Rate Investment Grade ETF
VRIG
|
+$12.9M |
| 2 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
+$11M |
| 3 |
Vanguard Total Bond Market
BND
|
+$9.68M |
| 4 |
Apple
AAPL
|
+$7.39M |
| 5 |
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
|
+$5.28M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 12.76% |
| 2 | Technology | 9.21% |
| 3 | Healthcare | 5.83% |
| 4 | Energy | 4.98% |
| 5 | Industrials | 4.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
AbbVie
ABBV
$431B
| $258K | 0.07% |
1,666
| – | – |
|
127
State Street SPDR Portfolio Mortgage Backed Bond ETF
SPMB
$7B
| $254K | 0.07% |
11,528
-2,382
| -17% | -$50.1K |
|
128
Kimberly-Clark
KMB
$37B
| $250K | 0.07% |
2,048
| – | – |
|
129
State Street SPDR S&P Bank ETF
KBE
$1.69B
| $246K | 0.07% |
+5,356
| New | +$212K |
|
130
Zoetis
ZTS
$31.9B
| $240K | 0.07% |
1,218
+41
| +3% | +$7.26K |
|
131
Invesco S&P 500 Quality ETF
SPHQ
$20B
| $233K | 0.07% |
+4,312
| New | +$222K |
|
132
Invesco QQQ Trust
QQQ
$485B
| $232K | 0.07% |
+566
| New | +$215K |
|
133
Waste Management
WM
$90B
| $225K | 0.06% |
+1,254
| New | +$210K |
|
134
Atlantic Union Bankshares
AUB
$6.16B
| $224K | 0.06% |
+6,137
| New | +$193K |
|
135
Alphabet (Google) Class A
GOOGL
$4.62T
| $224K | 0.06% |
+1,600
| New | +$215K |
|
136
Cardinal Health
CAH
$54.7B
| $217K | 0.06% |
+2,140
| New | +$212K |
|
137
Edison International
EIX
$27.2B
| $215K | 0.06% |
+3,000
| New | +$197K |
|
138
Walt Disney
DIS
$170B
| $213K | 0.06% |
+2,364
| New | +$208K |
|
139
Berkshire Hathaway Class B
BRK.B
$1.12T
| $210K | 0.06% |
+590
| New | +$207K |
|
140
Charter Communications
CHTR
$18.3B
| $208K | 0.06% |
537
| – | – |
|
141
Best Buy
BBY
$18.2B
| – | – |
-9,967
| Closed | -$654K |
|
142
Goodyear
GT
$2.07B
| – | – |
-44,028
| Closed | -$534K |
|
Similar funds
RC
DSA
MVP
RSS
STP
DFA
PCM
BAMG
Vectors Research Management's Q4 2023 Portfolio in Review
As of Q4 2023, Vectors Research Management held 142 positions worth $355M, up 15% from $309M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Vectors Research Management deployed $238M of net new capital in Q4 2023, opening 18 new positions and adding to 36 existing holdings. Its largest new stake was iShares Core S&P Small-Cap ETF: 78,869 shares worth $5M.
By sector, the portfolio is most concentrated in Consumer Staples at 13% of assets, up from 3% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Invesco Variable Rate Investment Grade ETF, an estimated $12.9M trimmed.
- Vectors Research Management's largest Q4 2023 buy was iShares Core S&P Small-Cap ETF: 78,869 shares worth $5M.
- Vectors Research Management added most to Eli Lilly in Q4 2023, an estimated $79.1M increase.
- Vectors Research Management's biggest Q4 2023 reduction was Invesco Variable Rate Investment Grade ETF, cutting an estimated $12.9M.
- Vectors Research Management fully exited Best Buy in Q4 2023, selling an estimated $654K.
- Vectors Research Management's ten largest holdings make up 43% of its $355M portfolio in Q4 2023.
- Vectors Research Management opened 18 new positions and closed 2 in Q4 2023.
- Vectors Research Management's portfolio value rose 15% quarter-over-quarter to $355M.
Based on Vectors Research Management's 13F filing for Q4 2023, filed 12 Feb 2024.